Used in pharmaceutical synthesis as an intermediate for developing neuroactive compounds, particularly in the production of nicotinic acetylcholine receptor modulators. It serves as a building block in the creation of drug candidates targeting cognitive disorders such as Alzheimer's disease and schizophrenia. Its structure allows for selective binding and improved metabolic stability in central nervous system agents. Also employed in research settings to design novel pyridine-based bioactive molecules with enhanced solubility and bioavailability.